688578:SSEShanghai Allist Pharmaceuticals Co. Ltd. Class A Analysis
Data as of 2026-08-21 - not real-time
CN¥116.50
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Shanghai Allist Pharmaceuticals Co., Ltd. trades at ¥116.50, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it lost 5.2%. Momentum indicators put RSI at 50.1 (neutral) with MACD reading bearish. Recent trading has carved out support near ¥105.52 and resistance around ¥123.96.
The shares look fair, trading on 19.6 times earnings below a sector average of 30.7. Revenue is growing at 36.1% on a 43.7% profit margin. The 0.83% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 61.9%, a beta of 0.21 and a maximum drawdown of 32.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
The shares look fair, trading on 19.6 times earnings below a sector average of 30.7. Revenue is growing at 36.1% on a 43.7% profit margin. The 0.83% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 61.9%, a beta of 0.21 and a maximum drawdown of 32.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 100.95
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 19.6 versus sector average of 30.7
- Trading above the 200-day average of 100.95
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 19.6 versus sector average of 30.7
- Profit margin of 43.7% is healthy
- Revenue growth of +36.1%
Key Metrics & Analysis
Financial Health
Revenue Growth36.10%
Profit Margin43.67%
P/E Ratio19.6
ROE36.71%
ROA22.96%
Debt/Equity0.02
P/B Ratio6.2
Op. Cash FlowCN¥2.7B
Free Cash FlowCN¥1.3B
Industry P/E30.7
Technical Analysis
TrendBullish
RSI50.1
SupportCN¥105.52
ResistanceCN¥123.96
MA 20CN¥115.99
MA 50CN¥112.99
MA 200CN¥100.95
MACDBearish
VolumeIncreasing
Fear & Greed Index93.39
Valuation
Fair ValueCN¥108.95
GradeFair
TypeGrowth
Dividend Yield0.83%
Risk Assessment
Beta0.21
Volatility61.94%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.